Geron reported $520.27M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Amgen USD 29.06B 1.17B Dec/2025
Bio Techne USD 637.43M 27.92M Dec/2025
Cassava Sciences USD 97.71M 11.2M Dec/2025
Cytokinetics USD 916.97M 60.37M Dec/2025
Esperion Therapeutics USD 462.57M 102.11M Dec/2025
Exelixis USD 1.44B 41.03M Dec/2025
Genmab DKK 2.88B 1.59B Dec/2025
Geron USD 520.27M 2.07M Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
Incyte USD 5.02B 746.01M Dec/2025
MacroGenics USD 219.94M 12.15M Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Novavax USD 978.28M 3.69M Dec/2025